The Bacteroides-Prevotella group encompasses two significant genera within the Bacteroidetes phylum, playing crucial roles in the human gut microbiome.
Originally classified together, Bacteroides and Prevotella were separated in 1990 due to their distinct characteristics.
Bacteroides is more prevalent in industrialized populations with Western diets high in animal protein and saturated fats, while Prevotella is commonly found in non-Western populations consuming plant-rich diets.
These bacteria exhibit a unique antagonistic relationship, with one typically dominating over the other in an individual's gut.
They are involved in breaking down complex carbohydrates, producing short-chain fatty acids, and influencing immune responses and nutrient metabolism.
The balance between these genera, often assessed by the Prevotella-to-Bacteroides (P/B) ratio, is crucial for gut health, influencing metabolic functions and potentially playing a role in various diseases.
Despite their beneficial roles, imbalances in their levels can lead to adverse health effects, highlighting the importance of understanding their interactions and impacts on the human microbiome.
Bacteroides and Prevotella are two significant genera within the phylum Bacteroidetes that play crucial roles in the human gut microbiome.
Although historically part of the same genus, they were separated in 1990.
Both are Gram-negative, anaerobic bacteria known for their high adaptability to various environmental conditions and diets, as well as their ability to utilize complex polysaccharides and mucins.
Their distribution in human populations differs notably: Bacteroides is more common in industrialized populations with Western diets, while Prevotella is more prevalent in non-Westernized populations with plant-rich diets. [3., 17., 20.]
This distribution reflects their dietary associations, with Bacteroides linked to diets high in animal protein and saturated fats, and Prevotella associated with diets rich in complex carbohydrates, fruits, and vegetables. [17., 20.]
These genera tend to have an antagonistic relationship in the gut microbiome, with one usually dominating over the other in an individual's gut.
Both genera are involved in important metabolic functions, including breaking down complex carbohydrates, producing short-chain fatty acids and other metabolites, and participating in vitamin synthesis and protein metabolism.
Their impact on human health can be both beneficial and potentially harmful, depending on the context, and they significantly influence overall gut microbiome composition and function.
These taxa are often analyzed based on their relative abundance and ratio to each other, known as the Prevotella-to-Bacteroides (P/B) ratio.
Bacteroides spp. are essential members of the human gut microbiota, playing a crucial role in maintaining gut homeostasis.
Along with Prevotella and Porphyromonas, they belong to the Bacteroidetes phylum.
The proportion of Bacteroidetes varies by population, geography, age, and diet.
Bacteroides spp. are gram-negative, non-spore forming, anaerobic, rod-shaped bacteria, with approximately 24 identified species. Among these, Bacteroides fragilis and Bacteroides thetaiotaomicron are the most studied.
These bacteria thrive in anaerobic conditions, utilizing complex polysaccharides for energy through fermentation, and are efficient in degrading dietary fibers and carbohydrates, producing short-chain fatty acids (SCFAs) and other metabolites that impact host physiology.
Bacteroides spp. use a Type VI secretion system (T4SS) to release toxins targeting other bacteria, maintaining a competitive advantage and stabilizing the gut ecosystem. They are key contributors to the microbial community in the colon, influencing immune responses, nutrient metabolism, and intestinal barrier function.
Primarily found in the distal gut, they ferment indigestible polysaccharides, producing SCFAs crucial for gut health, glucose homeostasis, and lipid metabolism.
Bacteroides adapt flexibly to the gut's nutritional environment, utilizing a wide range of dietary polysaccharides and proteins, aided by numerous carbohydrate-active enzymes (CAZYmes).
Diet significantly affects Bacteroidetes levels. Traditional diets high in fiber and complex carbohydrates are associated with a higher prevalence of Bacteroides, contributing to better metabolic health. [18.]
Conversely, modern diets high in animal products, processed and high-fat foods may reduce Bacteroides levels, potentially impacting gut homeostasis and overall health. [18.]
Overnutrition decreases Bacteroidetes, affecting energy harvest efficiency, while undernutrition and fasting can either increase or deplete Bacteroidetes levels, depending on the conditions.
Studies show varied associations between Bacteroidetes and type 2 diabetes, with specific species affecting host metabolism differently.
Although some studies show a healthy amount of Bacteroides is beneficial for metabolic health, the effects on glucose metabolism can vary significantly depending on dietary context and relative levels of Bacteroides subspecies. [7.]
Imbalances in gut microbiota, including alterations in Bacteroides spp. abundance, are linked to numerous diseases.
Bacteroides have shown potential in preventing and treating non-alcoholic fatty liver disease (NAFLD) by modulating gut health, reducing liver inflammation, mitigating hepatic steatosis, and enhancing intestinal barrier function.
Overall, modulating Bacteroides metabolism through dietary interventions holds potential for restoring gut microbiota balance and promoting metabolic health.
Prevotella is a diverse genus of Gram-negative anaerobic bacteria, first described in 1990 by Shar and Collins.
The genus includes oral species with saccharolytic capabilities and bile salt sensitivity, previously classified under Bacteroides.
Prevotella species are non-spore-forming, non-motile short rods, mostly saccharolytic, and part of the family Prevotellaceae, which also includes Paraprevotella, Alloprevotella, and Hallella.
Prevotella spp. are found in various animal hosts and free-living environments. They are common in mammal-associated microbiomes, inhabiting human skin, oral cavity, vagina, and gastrointestinal tract.
Prevotella dominance is notable in non-Westernized populations with traditional diets, while Westernized populations see a decreased prevalence of Prevotella, often replaced by Bacteroides species. This suggests that modern lifestyles contribute to the loss of Prevotella diversity, with potential health consequences. [17.]
Prevotella contains more than 50 characterized species, primarily associated with humans. They play significant roles in the microbiome balance between health and disease, influenced by diet, lifestyle, and geography.
Although their exact role in health and disease is unclear, they are implicated in inflammatory autoimmune diseases, bacterial vaginosis, and oral biofilm formation. [17.]
There are conflicting reports on whether Prevotella spp. are beneficial or detrimental to health, especially in glucose homeostasis. [17.]
Prevotella spp. exhibit extensive diversity and are found in various human body sites. They are particularly prevalent in non-Westernized populations and non-Western diets rich in carbohydrates and fiber, suggesting a diet and lifestyle influence. [17.]
Age and sex also affect their distribution, with some species more prevalent in elderly individuals and others linked to female hormone metabolism. [17.]
Prevotella spp. are essential in microbial ecology, especially in the gut, where they help digest complex polysaccharides. Studies suggest a link between Prevotella and improved glucose metabolism and weight loss with fiber-rich diets, although some studies associate Prevotella with insulin resistance. [17.]
Prevotella's role as potential pathogens includes associations with oral infections, autoimmune diseases, and systemic infections. However, their pathogenic potential is mainly opportunistic.
Antibiotic resistance in Prevotella is a growing concern, particularly resistance to β-lactam antibiotics and metronidazole. [17.]
Overall, Prevotella spp. are key players in the human microbiome, with significant implications for health and disease. Further research is needed to understand their ecological roles, interactions with the human host, and impact on health, particularly in the context of dietary and lifestyle changes associated with Westernization.
The gut microbiome plays a crucial role in the development and progression of colorectal cancer (CRC).
Significant dysbiosis has been noted in the gut microbiota composition in colorectal cancer (CRC) patients compared to individuals with normal colonoscopies. [16.]
Analyzing stool samples from 60 CRC patients and 119 controls using pyrosequencing and qPCR, they found that the Bacteroides/Prevotella group was significantly higher in CRC patients. [16.]
This elevation correlated with increased IL17-producing cells in the mucosa, suggesting a link between microbial imbalance and mucosal immune responses.
The Bacteroides/Prevotella ratio might serve as a potential marker for CRC and emphasizes the importance of gut microbiota in colorectal cancer pathophysiology.
The ratio of Prevotella to Bacteroides (P/B) in the gut microbiota can predict weight loss success on different diets.
Over 24 weeks, participants with a high P/B ratio lost significantly more body weight and fat, especially on a high-fiber diet, compared to those with a low P/B ratio. [4.]
This suggests that individuals with a higher P/B ratio respond better to fiber-rich diets, highlighting the potential of using gut microbiota composition to personalize weight loss strategies.
One study confirms that a high P/B ratio is associated with greater susceptibility to diet-induced weight loss, emphasizing the importance of dietary fiber in managing body weight. [4.]
Recent research highlights the critical role of gut dysbiosis in obesity and type 2 diabetes (T2D), emphasizing how shifts in gut microbial diversity and abundance of pathogenic bacteria can disrupt metabolic homeostasis, worsen triglyceride and cholesterol levels, and instigate chronic inflammation. [11.]
This dysbiosis impacts the gut-brain axis, leading to insulin resistance, and also influences visceral adipose tissue function in obese individuals with T2D.
A particular focus is on the Bacteroides and Prevotella groups. An increased ratio of Prevotella to Bacteroides has been associated with diets high in carbohydrates and fibers and linked to improved glucose homeostasis and weight management.
Conversely, shifts favoring Bacteroides over Prevotella are often observed in high-fat diets and linked to metabolic disturbances.
The complex interaction between diet, gut microbiota, and microbial metabolites plays a significant role in T2D pathogenesis. Gut-derived metabolites such as short-chain fatty acids (SCFAs) and bile acids can influence lipid metabolism, inflammation, and insulin sensitivity.
Specific microbial alterations, including an increase in Firmicutes and a reduction in Bacteroidetes, to which Prevotella and Bacteroides belong, have been associated with obesity and its metabolic complications. [11.]
Therapeutic strategies targeting gut microbiota, such as probiotics, prebiotics, and fecal microbial transplantation, show promise in managing T2D by modulating the gut microbiome, improving gut barrier function, and reducing systemic inflammation. [11.]
The gut microbiome significantly influences sarcopenia, a condition characterized by muscle mass loss and functional decline. [9.]
One study showed that non-sarcopenia participants had enriched branched-chain amino acid (BCAA) metabolism, with lower levels of BCAA-related metabolites in sarcopenia patients. [9.]
In a mouse model, gavaging with live P. copri (LPC) resulted in higher blood BCAA levels, improved muscle function, and increased muscle mass.
These findings suggest that P. copri can mitigate muscle mass and function decline, indicating its therapeutic potential for managing sarcopenia.
Research highlights the gut-muscle axis's crucial role, mediated by the gut microbiome, in muscle health.
Overall, targeting the gut microbiota, particularly through enhancing levels of P. copri and BCAA, could be an effective strategy for treating sarcopenia.
Bacteroides-Prevotella Group levels are assessed in stool samples. Stool samples may be collected from the comfort of home.
Testing may require avoidance of certain medications and/or supplements including probiotics prior to sample collection. It is important to consult with the ordering provider for full test preparation instructions.
It is important to consult with the laboratory company used for test interpretation.
One lab company provides the following reference range for Bacteroides spp. levels alongside Prevotella spp., and reports this on a scale from -3 (low prevalence of these organisms) to +3 (high prevalence of these organisms). [13.]
Another company provides the following range for the Bacteroides-Prevotella Group: 3.4E6 - 1.5E9 CFU/g stool. [14.]
Optimal levels are recommended to fall within this range, as excessively high or low levels may be associated with health conditions.
An elevated Bacteroides-Prevotella group indicates an increased presence of these organisms in an individual’s microbiome.
The clinical significance of an elevated Bacteroides-Prevotella group is multifaceted and closely tied to dietary patterns and metabolic functions.
This group is generally associated with a Western diet high in animal protein and saturated fats, with a Bacteroides-dominated microbiome positively correlated with long-term consumption of such diets. Metabolically, these bacteria play important roles.
Elevated levels of Bacteroides-Prevotella are associated with reduced bacterial gene richness in the gut microbiome, potentially impacting overall microbial diversity. [6.] Altered levels may also have clinical implications regarding metabolic health and weight management.
While these bacteria are normally part of the gut microbiota, they can become opportunistic pathogens under certain conditions. Bacteroides species, in particular, are significant clinical pathogens present in most anaerobic infections and can be associated with mortality. [2.]
As members of the Bacteroidetes phylum, decreased levels of Bacteroides-Prevotella signify a decrease in Bacteroidetes levels.
When assessing overall microbial balance, the Bacteroidetes/Firmicutes ratio holds clinical significance, as a decreased Bacteroidetes/Firmicutes ratio has been associated with poorer metabolic health and increased weight gain.
Several studies have found an association between high Bacteroidetes levels and a lean phenotype or healthy weight. A higher Bacteroidetes/Firmicutes ratio was associated with a lower body mass index (BMI). [7., 10.]
A healthy diet and lifestyle are foundational for microbiome health.
The Bacteroides-Prevotella group comprises two prominent genera of bacteria that play significant roles in the human gut microbiome. This FAQ section addresses common questions about the Bacteroides-Prevotella group, their functions, and their impact on health.
The Bacteroides-Prevotella group includes two genera of Gram-negative, anaerobic bacteria: Bacteroides and Prevotella. These bacteria are prevalent in the human gut microbiome and are essential for the digestion of complex carbohydrates and maintaining gut health.
Bacteroides and Prevotella bacteria help break down complex carbohydrates, producing short-chain fatty acids and other metabolites that support gut health.
Bacteroides are more involved in the digestion of proteins and animal fats, while Prevotella is associated with the breakdown of plant-based fibers and carbohydrates.
Bacteroides and Prevotella can be detected using microbiological and molecular techniques such as stool culture, 16S rRNA gene sequencing, and metagenomic analysis. These methods allow for the identification and quantification of these bacteria in the gut microbiome.
The benefits of Bacteroides and Prevotella include:
While Bacteroides and Prevotella are generally beneficial, an imbalance in the gut microbiome (dysbiosis) can lead to overgrowth of these bacteria, potentially contributing to gastrointestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other metabolic conditions.
Bacteroides and Prevotella interact with each other and other gut bacteria through competitive and cooperative relationships. These interactions help maintain a balanced gut microbiome, where beneficial bacteria support each other's growth and function while keeping pathogenic bacteria in check.
Supporting a healthy balance of Bacteroides and Prevotella involves:
You should consult a healthcare provider if you experience persistent digestive issues such as abdominal pain, bloating, diarrhea, or constipation. A healthcare provider can evaluate your symptoms, potentially recommend microbiome testing, and suggest appropriate treatments or dietary changes to improve gut health.
Click here to compare testing options and order testing for Bacteroides-Prevotella Group testing.
[1.] Bacteroidetes: The Jekyll and Hyde of the Human Gut Microbiome. Pharmacy Times. https://www.pharmacytimes.com/view/bacteroidetes-the-jekyll-and-hyde-of-the-human-gut-microbiome
[2.] Elsaghir H, Reddivari AKR. Bacteroides Fragilis. [Updated 2023 May 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553032/
[3.] Gorvitovskaia, A., Holmes, S.P. & Huse, S.M. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 4, 15 (2016). https://doi.org/10.1186/s40168-016-0160-7
[4.] Hjorth, M.F., Blædel, T., Bendtsen, L.Q. et al. Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis. Int J Obes 43, 149–157 (2019). https://doi.org/10.1038/s41366-018-0093-2
[5.] Hou, K., Wu, ZX., Chen, XY. et al. Microbiota in health and diseases. Sig Transduct Target Ther 7, 135 (2022). https://doi.org/10.1038/s41392-022-00974-4
[6.] Iljazovic A, Roy U, Gálvez EJC, Lesker TR, Zhao B, Gronow A, Amend L, Will SE, Hofmann JD, Pils MC, Schmidt-Hohagen K, Neumann-Schaal M, Strowig T. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation. Mucosal Immunol. 2021 Jan;14(1):113-124. doi: 10.1038/s41385-020-0296-4. Epub 2020 May 20. PMID: 32433514; PMCID: PMC7790746.
[7.] Johnson EL, Heaver SL, Walters WA, Ley RE. Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl). 2017 Jan;95(1):1-8. doi: 10.1007/s00109-016-1492-2. Epub 2016 Nov 29. PMID: 27900395; PMCID: PMC5187364.
[8.] JOHNSON JL, AULT DA. Taxonomy of the Bacteroides: II. Correlation of Phenotypic Characteristics with Deoxyribonucleic Acid Homology Groupings for Bacteroides fragilis and Other Saccharolytic Bacteroides Species. International Journal of Systematic Bacteriology. 1978;28(2):257-268. doi:https://doi.org/10.1099/00207713-28-2-257
[9.] Liu X, Wu J, Tang J, Xu Z, Zhou B, Liu Y, Hu F, Zhang G, Cheng R, Xia X, Chen Y, Wu H, Wang D, Yue J, Dong B, Fu J, Yu H, Dong B. Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2275-2288. doi: 10.1002/jcsm.13313. Epub 2023 Aug 17. PMID: 37591518; PMCID: PMC10570070.
[10.] Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, Hattori M. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 2016 Apr;23(2):125-33. doi: 10.1093/dnares/dsw002. Epub 2016 Mar 6. PMID: 26951067; PMCID: PMC4833420.
[11.] Patra D, Banerjee D, Ramprasad P, Roy S, Pal D, Dasgupta S. Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes. Front Mol Biosci. 2023 Sep 28;10:1224982. doi: 10.3389/fmolb.2023.1224982. PMID: 37842639; PMCID: PMC10575740.
[12.] Roager HM, Licht TR, Poulsen SK, Larsen TM, Bahl MI. Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. Appl Environ Microbiol. 2014 Feb;80(3):1142-9. doi: 10.1128/AEM.03549-13. Epub 2013 Dec 2. PMID: 24296500; PMCID: PMC3911217.
[13.] Rupa Health. GI360 Microbiome Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1hxpopw13KhiKJyZ9XnKPkfJBb8_4zP23/view
[14.] Rupa Health. 1.GI Effects Comprehensive Profile Sample Report.pdf. Google Docs. Accessed July 7, 2024. https://drive.google.com/file/d/1Hy3yDV4CVxaxTtXHDILdkcYRyrLECuCI/view
[15.] Shin JH, Tillotson G, MacKenzie TN, Warren CA, Wexler HM, Goldstein EJC. Bacteroides and related species: The keystone taxa of the human gut microbiota. Anaerobe. 2024 Feb;85:102819. doi: 10.1016/j.anaerobe.2024.102819. Epub 2024 Jan 10. PMID: 38215933.
[16.] Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial Dysbiosis in Colorectal Cancer (CRC) Patients. Pied S, ed. PLoS ONE. 2011;6(1):e16393. doi:https://doi.org/10.1371/journal.pone.0016393
[17.] Tett, A., Pasolli, E., Masetti, G. et al. Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol 19, 585–599 (2021). https://doi.org/10.1038/s41579-021-00559-y
[18.] Thomas F, Hehemann JH, Rebuffet E, Czjzek M, Michel G. Environmental and gut bacteroidetes: the food connection. Front Microbiol. 2011 May 30;2:93. doi: 10.3389/fmicb.2011.00093. PMID: 21747801; PMCID: PMC3129010.
[19.] Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007 Oct;20(4):593-621. doi: 10.1128/CMR.00008-07. PMID: 17934076; PMCID: PMC2176045.
[20.] Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011 Oct 7;334(6052):105-8. doi: 10.1126/science.1208344. Epub 2011 Sep 1. PMID: 21885731; PMCID: PMC3368382.
[21.] Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10452-9. doi: 10.1073/pnas.1734063100. Epub 2003 Aug 15. PMID: 12923294; PMCID: PMC193582.